Study to Assess the Safety, Tolerability, and Efficacy of Tipifarnib Plus Bortezomib in the Treatment of Acute Myeloid Leukemia (HEMOS AML 0106)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by University of Bologna.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Janssen-Cilag Ltd.
Information provided by:
University of Bologna
ClinicalTrials.gov Identifier:
NCT00510939
First received: August 2, 2007
Last updated: August 13, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given